0
0
0
Access to Breast Cancer Diagnosis Act of 2021
12/30/2022, 7:33 AM
Summary of Bill HR 5769
Bill 117 HR 5769, also known as the Access to Breast Cancer Diagnosis Act of 2021, aims to improve access to breast cancer screening and diagnosis for women across the United States. The bill focuses on increasing funding for mammograms and other diagnostic tests, as well as ensuring that women have access to timely and accurate information about their breast health.
One key provision of the bill is the establishment of a grant program to help healthcare providers offer free or low-cost mammograms to women who may not otherwise be able to afford them. This program would also provide funding for outreach and education efforts to raise awareness about the importance of early detection and screening for breast cancer.
Additionally, the bill includes measures to improve the quality and accuracy of breast cancer screenings, such as requiring healthcare providers to follow best practices for interpreting mammograms and other diagnostic tests. The bill also calls for increased research funding to support the development of new and improved screening technologies. Overall, the Access to Breast Cancer Diagnosis Act of 2021 seeks to address disparities in access to breast cancer screening and diagnosis, particularly among underserved communities. By increasing funding, improving quality standards, and promoting education and outreach efforts, the bill aims to ensure that all women have the opportunity to receive timely and accurate information about their breast health.
One key provision of the bill is the establishment of a grant program to help healthcare providers offer free or low-cost mammograms to women who may not otherwise be able to afford them. This program would also provide funding for outreach and education efforts to raise awareness about the importance of early detection and screening for breast cancer.
Additionally, the bill includes measures to improve the quality and accuracy of breast cancer screenings, such as requiring healthcare providers to follow best practices for interpreting mammograms and other diagnostic tests. The bill also calls for increased research funding to support the development of new and improved screening technologies. Overall, the Access to Breast Cancer Diagnosis Act of 2021 seeks to address disparities in access to breast cancer screening and diagnosis, particularly among underserved communities. By increasing funding, improving quality standards, and promoting education and outreach efforts, the bill aims to ensure that all women have the opportunity to receive timely and accurate information about their breast health.
Congressional Summary of HR 5769
Access to Breast Cancer Diagnosis Act of 2021
This bill prohibits private health insurance plans from imposing higher cost-sharing requirements on breast cancer diagnostic examinations than initial breast cancer screening examinations. Diagnostic examinations are generally required after an initial screening detects an abnormality and typically require additional mammogram images (e.g., x-rays).
Read the Full Bill
Current Status of Bill HR 5769
Bill HR 5769 is currently in the status of Bill Introduced since October 28, 2021. Bill HR 5769 was introduced during Congress 117 and was introduced to the House on October 28, 2021. Bill HR 5769's most recent activity was Referred to the Subcommittee on Health. as of October 29, 2021
Bipartisan Support of Bill HR 5769
Total Number of Sponsors
1Democrat Sponsors
1Republican Sponsors
0Unaffiliated Sponsors
0Total Number of Cosponsors
96Democrat Cosponsors
74Republican Cosponsors
22Unaffiliated Cosponsors
0Policy Area and Potential Impact of Bill HR 5769
Primary Policy Focus
HealthAlternate Title(s) of Bill HR 5769
Access to Breast Cancer Diagnosis Act of 2021
Access to Breast Cancer Diagnosis Act of 2021
To amend title XXVII of the Public Health Service Act to prohibit group health plans and health insurance issuers offering group or individual health insurance coverage from imposing cost-sharing requirements or treatment limitations with respect to diagnostic examinations for breast cancer that are less favorable than such requirements with respect to screening examinations for breast cancer.
Comments
Sponsors and Cosponsors of HR 5769
Latest Bills
National Defense Authorization Act for Fiscal Year 2026
Bill S 1071December 13, 2025
Enduring Justice for Victims of Trafficking Act
Bill S 2584December 13, 2025
Technical Corrections to the Northwestern New Mexico Rural Water Projects Act, Taos Pueblo Indian Water Rights Settlement Act, and Aamodt Litigation Settlement Act
Bill S 640December 13, 2025
Incentivizing New Ventures and Economic Strength Through Capital Formation Act of 2025
Bill HR 3383December 13, 2025
BOWOW Act of 2025
Bill HR 4638December 13, 2025
Northern Mariana Islands Small Business Access Act
Bill HR 3496December 13, 2025
Wildfire Risk Evaluation Act
Bill HR 3924December 13, 2025
Energy Choice Act
Bill HR 3699December 13, 2025
ESTUARIES Act
Bill HR 3962December 13, 2025
Improving Interagency Coordination for Pipeline Reviews Act
Bill HR 3668December 13, 2025





